2025
In an interview with South Africa’s eNCA, our CEO Guido Geerts shared insights on the transformative collaboration between Delft Imaging and EPCON – and how CAD4TB+ is at the center of it.
Health & Science Africa featured CAD4TB+ as a major step forward in the fight against TB, describing it as a solution that “could significantly reshape how tuberculosis is detected, monitored, and controlled across high-burden settings.”
In a Sunday Times feature, our CEO, @Guido Geerts, explains how AI-powered diagnostics are transforming TB detection in South Africa and beyond.
2026
In January 2026, the Sunday Times reported on the role of CAD4TB in tuberculosis (TB) detection in South Africa as part of its feature on the country’s public health priorities for 2026.
The article featured Delft Imaging CEO Guido Geerts, who discussed how AI-supported chest X-ray analysis is helping strengthen TB screening. CAD4TB, originally developed to support TB programs in resource-limited settings, has now analyzed more than 30 million chest X-rays worldwide.